Enzymotec launches product for diabetes patients
Israeli firm Enzymotec has developed a novel product line marketed under the brand carDiabeat, designed to fight the major risks for cardiovascular disorders of diabetes patients.
Israeli firm Enzymotec has developed a novel product line marketed under the brand carDiabeat, designed to fight the major risks for cardiovascular disorders of diabetes patients.
A compound in the curry spice turmeric appears to correct the cystic fibrosis defect in mice, report Canadian scientists, demonstrating the potential for treating the disease in humans.
Speciality chemicals firm Degussa is investing €10 million in a new research and development centre in Shanghai, where its numerous business units, including food ingredients, will seek to develop products targeted for the Chinese market.
Canadian sterol manufacturer Forbes Medi-Tech has significantly cut its losses after sales of the cholesterol-lowering ingredient shot up more than 80 per cent during 2003.
A New Zealand biotech firm is entering its first foreign market, China, with a product containing a proprietary bacterial strain said to fight off sore throats.
Black women may need to increase their folic acid intake, as a new report shows that higher levels of the amino acid homocysteine and less folic acid than white women could be increasing their risk of preeclampsia during pregnancy.
Some supplements targeted at professional athletes contain banned substances which are not listed on their labels, according to new research.